Meeder Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1
Closed 1301
2021
Q3
$0 Sell
1
-1
-50% -$286 ﹤0.01% 2483
2021
Q2
$1K Hold
2
﹤0.01% 2310
2021
Q1
$1K Hold
2
﹤0.01% 2181
2020
Q4
$1K Hold
2
﹤0.01% 1609
2020
Q3
$2K Sell
2
-3
-60% -$2.34K ﹤0.01% 1806
2020
Q2
$4K Sell
5
-8
-62% -$6.03K ﹤0.01% 1563
2020
Q1
$8K Buy
13
+8
+160% +$7.8K ﹤0.01% 1603
2019
Q4
$6K Hold
5
﹤0.01% 1703
2019
Q3
$6K Buy
5
+2
+67% +$3.05K ﹤0.01% 1690
2019
Q2
$5K Buy
+3
New +$5.19K ﹤0.01% 1653
2018
Q3
Sell
-16
Closed -$32.8K 1544
2018
Q2
$32.8K Sell
16
-24
-60% -$54.7K ﹤0.01% 862
2018
Q1
$89K Sell
40
-9
-18% -$22.9K 0.01% 567
2017
Q4
$114K Buy
49
+47
+2,350% +$95.4K 0.01% 547
2017
Q3
$4K Hold
2
﹤0.01% 1314
2017
Q2
$3K Buy
+2
New +$2.41K ﹤0.01% 1313
2015
Q3
Sell
-996
Closed -$2.17M 692
2015
Q2
$2.17M Buy
+996
New +$2.03M 0.22% 136

Other funds holding BLUE

Meeder Asset Management's BLUE Position: Q4 2021 in Review

Meeder Asset Management sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 1 share.

Meeder Asset Management first reported a position in BLUE in Q2 2015 and held it in 16 quarters. The position peaked at $2.17M in Q2 2015. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Meeder Asset Management reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 1 bluebird bio share in Q4 2021.
  • Meeder Asset Management first reported a position in bluebird bio in Q2 2015 and held it in 16 quarters.
  • Meeder Asset Management's bluebird bio position peaked at $2.17M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.